Stay updated on GVAX & Pembrolizumab in MMR-p CRC Clinical Trial

Sign up to get notified when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-06T15:53:31.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    - Revision label updated from v3.4.1 to v3.4.2 on the page. This is a minor frontend/version change that does not affect study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-02-12T20:49:03.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Site updated to Revision v3.4.1. The study page content and functionality remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T12:15:49.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The only visible change is the updated revision tag: Revision: v3.3.4 replacing the previous Revision: v3.3.3 on the Study Documents section. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T03:08:13.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Added a Locations section showing Maryland as a study site; updated the page to revision v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T15:00:55.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    A clarifying line about publications being provided voluntarily has been added to the Publications section, and a revision tag (v3.3.2) appears, while the previous wording for v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-25T14:29:12.000Z thumbnail image

Stay in the know with updates to GVAX & Pembrolizumab in MMR-p CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.